조직 내 항균제 농도를 고려한 항균제 감수성 검사의 판독

참고문헌 (20)

1. "Principles of Anti-infective Therapy", pp.242~702 (2005), Churchill Livingstone
2. "The Sanford guide to antimicrobial therapy" (2005), Antimicrobial Therapy Inc
3. "Rational dosing of antibiotics:the use of plasma concentrations versus tissue concentrations", 19, pp.285~290 (2002)
4. "Extravascular antimicribial distribution and the respective blood and urine concentrations in humans. In: Lorian V, ed. Antibiotics in Laboratory Medicine" (2005), Lippincott Williams & Wilkins
5. "Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement." (2006), Clinical and Laboratory Standards Institute
6. "Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing", 16, pp.784~93 (1982)
7. "Interpretation of antimicrobial susceptibility test of Enterobacteriaceaeto β-lactams with Expert System", 24, pp.377~385 (2004)
8. "Pharmacological indices in antibiotic therapy", 52, pp.893~898 (2003)
9. "Pharmacodynamics of antimicrobial drugs", 18, pp.451~465 (2004)
10. "Randomized comparative trial with ampicillin", sulbactam versus cefamandole in the therapy of community acquired pneumonia, 1994, pp.13, 293~8
11. "Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia", 44, pp.3418~3421 (2006)
12. "Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia", 30, pp.989~991 (2004)
13. "Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis:a report from the OPTAMA program", 8, pp.131~138 (2006)
14. "Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily", 39, pp.264~267 (1995)
15. "Serum pharmacokinetics and sputum penetration of amikacin 30 mg", kg once daily and of ceftazidime 200 mg, day as a continuous infusion in cystic fibrosis patients, 2001[DOI]
16. "Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets", 166, pp.1375~1381 (2002)
17. "Amikacin and colistin for treatment of Acinetobacter baumannii meningitis", 51, pp.249~251 (2005)
18. "Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges", 10, pp.511~4 (1991)
19. "Pharmacokinetic disposition of quinolones in human body fluids and tissues", 16, pp.5~24 (1989)
20. "Does the dose matter?", 33, pp.233~237 (2001)

관련 논문AI추천